Akari Therapeutics AKTX Balance Sheet (2011-2026)

NASDAQ AKTX
$7.13 -0.53 (-6.92%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Akari Therapeutics Quarterly Balance Sheet

Periods 44 quarters
Latest Jun 2026

Akari Therapeutics reported total assets of $38.62M and total liabilities of $20.03M for the quarter ended Jun 2026, down 24.1% year over year. This balance sheet covers 44 quarters of results from Dec 2011 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Dec2011 Dec2012 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
12.32M14.06M3.79M9.36M8.15M13.25M7.20M3.85M1.31M4.18M2.25M2.66M2.64M2.77M2.54M5.26M2.83M7.75M
Short-term InvestmentsInvestments (Current)
Cash & Current Investments
12.32M14.06M3.79M9.36M8.15M13.25M7.20M3.85M1.31M4.18M2.25M2.66M2.64M2.77M2.54M5.26M2.83M7.75M
Receivables - OtherOther Receivables
Prepaid Assets
1.35M0.29M1.01M2.17M3.09M0.47M0.63M0.30M1.23M0.81M0.40M0.09M0.63M0.45M0.35M0.19M0.73M0.53M
Current Assets
13.67M14.58M4.80M11.63M11.35M13.82M8.00M4.34M2.77M5.08M2.73M2.95M3.35M3.30M2.95M5.46M3.59M8.32M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
Goodwill
8.43M8.43M8.43M8.43M8.43M16.86M16.86M
Intangibles
0.03M0.03M0.03M0.02M0.02M0.02M0.02M0.01M39.18M39.18M39.18M34.00M34.00M30.30M30.30M
Goodwill & Intangibles
0.03M0.03M0.03M0.02M0.02M0.02M0.02M0.01M47.61M47.61M47.61M42.43M42.43M47.16M47.16M
Other Non-Current Assets
0.06M0.06M0.06M0.06M0.06M0.06M0.06M
Non-Current Assets
0.03M0.03M0.03M0.02M0.02M0.02M0.02M0.01M47.61M47.61M47.61M42.43M42.43M30.30M30.30M
Assets
13.69M14.60M4.83M11.65M11.37M13.83M8.01M4.36M2.77M5.08M2.73M50.56M50.96M50.91M45.38M47.89M33.89M38.62M
Liabilities
Current Liabilities
Accounts Payables
2.41M3.38M1.69M1.79M1.63M0.95M1.03M1.67M3.21M4.69M4.78M12.41M13.07M11.61M10.84M8.77M8.64M9.40M
Notes Payables
0.66M0.23M0.18M0.20M0.08M0.05M
Payables
2.41M3.38M1.69M1.79M1.63M0.95M1.03M1.67M3.21M4.69M4.78M13.07M13.30M11.79M11.04M8.85M8.69M9.40M
Accumulated Expenses
0.98M1.84M1.56M3.18M1.41M3.15M2.40M1.57M1.53M1.69M2.61M3.14M3.49M2.47M1.62M2.34M3.33M3.51M
Other Accumulated Expenses
0.13M0.09M0.09M0.98M0.65M0.32M0.73M0.80M0.65M0.48M0.45M0.70M0.58M
Total Current Liabilities
4.58M6.33M8.78M9.43M19.91M20.91M17.14M15.57M12.35M13.42M13.94M
Non-Current Liabilities
Non-Current Debt
1.65M0.70M0.70M0.10M
Convertible Debt
0.70M0.70M0.70M0.66M0.67M0.68M0.69M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
8.04M8.04M8.04M6.95M6.95M6.09M6.09M
Other Non-Current Liabilities
0.10M0.02M0.10M0.10M0.10M0.10M0.38M0.27M0.13M0.17M0.49M
Total Non-Current Liabilities
11.94M5.21M4.48M6.23M8.68M9.33M27.95M28.95M25.18M22.52M19.07M
Total Liabilities
6.75M5.22M3.24M6.09M3.05M12.04M5.23M4.58M6.33M8.78M9.43M28.33M29.21M25.31M22.69M19.56M19.51M20.03M
Shareholder's Equity
Total Debt
2.31M0.93M0.88M0.30M0.08M0.05M
Common Equity
6.95M9.38M1.59M5.56M8.33M1.79M6.56M2.78M0.21M-0.23M-3.55M-3.70M-6.69M22.23M21.75M25.61M22.69M28.33M14.38M18.60M
Liabilities and Shareholders Equity
13.69M14.60M4.83M11.65M11.37M13.83M8.01M4.36M2.77M5.08M2.73M50.56M50.96M50.91M45.38M47.89M33.89M38.62M
Retained Earnings
-175.47M-182.28M-192.47M-199.71M-210.56M-217.45M-220.50M-227.46M-233.03M-240.60M-243.50M-247.25M-251.00M-252.90M-259.30M-264.55M-279.01M-283.81M

Akari Therapeutics Balance Sheet API

Pull Akari Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AKTX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY